Long-Term Study for Participants Continuing Treatment from a Previous Exelixis Study
Sponsor: Exelixis
Sponsor score: 40
ClinicalTrials ID:NCT07620574
This study allows participants who were part of a previous Exelixis-sponsored study to continue receiving their treatment if they are benefiting from it and cannot access it locally.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The purpose of this long-term study is to provide ongoing access to treatment for participants who were part of a previous Exelixis-sponsored study and are still benefiting from the treatment. This is for those who cannot get the treatment in their local area.
Eligibility Criteria
Inclusion Criteria
- Eligible to continue receiving treatment from the previous study (meaning they have not been removed from the study for any reason).
- Still benefiting from the treatment at the time of moving from the previous study to this one, as determined by the study doctor.
- Able to follow the rules and requirements of this long-term study, as decided by the study doctor.
- Able to start the treatment in this extension study within the allowed time frame after the last treatment in the previous study.
Exclusion Criteria
- Meet any criteria for stopping treatment as specified in the previous study at the time of joining this extension study.
- The treatment is available and marketed in the participant's country for their specific condition and they can access it.
- Have received any other cancer treatment (other than what was allowed in the previous study) between the last treatment in the previous study and the first dose in this extension study.
- Have permanently stopped all study treatments for any reason during the previous study or between the last treatment in the previous study and the first dose in this extension study.
- Currently participating in any other treatment-based clinical trial (other than the previous study).
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| New York Cancer and Blood Specialists | 11706 | Bay Shore | New York |
| Greater Dayton Cancer Center | 45409 | Kettering | Ohio |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.
